Press Release

Best in Class: Scottsdale Wound Management Guide

Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips

Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More

2009 Author Index

CLICK HERE TO VIEW OUR 2009 AUTHOR INDEX

Non-Accredited Education

On-Demand! Wound Healing in Today’s Healthcare Environment – How Advanced Dressing Technology Can Help Ease the Strain
Non-Accredited

Managing the Diabetic Foot: A Clinical and Economic View Complimentary Archived Webcast
Non-Accredited

Head Over Heels and Butts 2.0
Complimentary Archived Webcast
Non-Accredited

Emerging Concepts in Treating Pressure Ulcers
Complimentary Archived Webcast
Non-Accredited

Understanding Collagen Dressings and their Benefit in Wound Care
Complimentary Archived Webcast
Non-Accredited

OWM News Wire

New cardiovascular horizons targets multidisciplinary approach to limb salvage and much more

New Cardiovascular Horizons ([NCVH] New Orleans, La), a multidisciplinary meeting focused on Peripheral artery disease (PAD) and peripheral interventions, will take place June 2–5, 2010. Entering its 11th year, NCVH is the longest running “head-to-toe” cardiovascular meeting to concentrate on limb salvage and amputation prevention techniques. Originally established in 2000 as a fall meeting, organizers moved the meeting ahead of hurricane season in 2009 in attempts to prevent any further weather related disruptions.

Not All Pressure Ulcers Are Avoidable

The National Pressure Ulcer Advisory Panel’s ([NPUAP] Washington, DC) recent consensus conference panelists agreed that patients who choose not to participate in their own pressure ulcer prevention could potentially develop unavoidable pressure ulcers. They also agreed that there are clinical situations in which the development of pressure ulcers is unavoidable. The conference was held at Johns Hopkins Medical Center (Baltimore, MD) and 24 multidisciplinary experts in pressure ulcer prevention and treatment comprised the voting panelists.

New adhesive silicone gels provide gentle adhesion to skin during wound healing

Bluestar Silicones (Anaheim, Calif), one of the world’s leading fully integrated global silicones manufacturers, recently launched a new line of skin adhesive elastomer gels. The new Silbione® Silicone Gels provide gentle, non-irritating adhesion for a range of wound and skin care applications. Wound care is a growing market for silicones because of the material’s property profile and biocompatibility. The gel skin adhesives are two-part, platinum-catalyzed silicone gel elastomers that are manufactured in a clean environment to ensure healthcare grade levels of purity and quality.

Wound care product stops bleeding and assists soldiers on the battlefield

Celox™ granules are high surface area flakes. When the flakes come in contact with blood, the product forms a robust gel like clot in 30 seconds. It works independently of the body’s normal clotting processes. The product’s clotting ability has been proven to work in the cold (hypothermia) or in the presence of common anti-coagulants such as warfarin. Since it does not generate heat, Celox will not burn the casualty or care giver. The product is made with chitosan, which is broken down by lysozyme, a human enzyme that leaves glucosamine, a sugar that is normally found in the body.

Serious Complications with Negative Pressure Wound Therapy – January 2010

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=94#2

Cepheid Receives FDA Clearance for Test for HAI-Associated Gene

Cepheid Wednesday announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert vanA, the first rapid and accurate test released in the United States for vanA, the antimicrobial resistance gene most commonly associated with vancomycin-resistant enterococci — one of the more serious healthcare-associated infections (HAI).
Fox Business

Rare but Be Aware: Serious Complications Associated with Negative Pressure Wound Therapy Systems

FDA Preliminary Public Health Notification*: Serious Complications Associated with Negative Pressure Wound Therapy Systems

Date: November 13, 2009

Dear Healthcare Practitioner:

This is to alert you to deaths and serious complications, especially bleeding and infection, associated with the use of Negative Pressure Wound Therapy (NPWT) systems, and to provide recommendations to reduce the risk. Although rare, these complications can occur wherever NPWT systems are used, including acute and long-term healthcare facilities and at home. FDA has received reports of six deaths and 77 injurie

Skin substitute company outlines strategic growth plan

Advanced BioHealing Inc (Westport, CT) announced a strategic growth plan designed to continue to transform the company into a leading international regenerative medicine company. The company manufactures and markets Dermagraft®, a bioengineered skin substitute that repairs tissue damage caused by disease or injury and supports the body’s natural healing process in patients with diabetic foot ulcers. To spur future growth, executive management has outlined a growth strategy to leverage current successes, develop its international presence, address new applications, and expand its product lin

Company pursuing Japanese market

Kinetic Concepts Inc (San Antonio, TX) announced that the Ministry of Health, Labor and Welfare (MHLW) will grant regulatory approval of market development activities at the Pharmaceutical and Medical Devices Agency (PMDA) in Japan for its V.A.C.® Therapy product.

The company anticipates the MHLW will ensure that all necessary regulatory steps have been addressed before the application is taken to the Minister’s Office for a signature. Following regulatory approval, the company expects reimbursement will be provided in the first half of 2010. Once reimbursement approval is obtained, th

First randomized clinical trial results for powder dressing announced

Uluru Inc (Addison, Tex) presented results from the first completed randomized clinical trial for Altrazeal™ Transforming Powder Dressing at the Symposium on Advanced Wound Care (SAWC) Fall Symposium, which took place in Washington D.C., September 16–18, 2009. The dressing utilizes proprietary nanoflex™ technology to promote the healing of exuding wounds. The recently completed clinical study compared healing, pain, and comfort of skin graft donor sites treated with either the dressing or with a leading commercial sodium carboxymethylcellulose-silver (“CMC-Ag”) dressing. Major result